Home Others Others Fat Emulsion（20%）

research use only

Fat Emulsion（20%）

Cat.No.E2950

Fat Emulsion（20%）is a safe fat emulsion that can be used as a nutritional supplement. It inhibits the opening of the mitochondrial permeability transition pore and effectively protecting the heart from ischaemia-reperfusion injury. It has some potential to modulate the innate immune response.
Fat Emulsion（20%） Chemical Structure

Chemical Structure

Jump to

Quality Control

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight Formula Storage (From the date of receipt) 2 years  -20°C  liquid
CAS No. 68890-65-3 --

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-12-10)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06126380 ENROLLING_BY_INVITATION
Kidney Transplant Rejection
Eledon Pharmaceuticals
 2023-10-25 PHASE2
NCT05683132 ACTIVE_NOT_RECRUITING
Insomnia; PTSD; Women Veterans
VA Office of Research and Development
 2023-06-01
NCT05612594 RECRUITING
Sleep Apnea
Yale University
 2024-03-27 PHASE4
NCT05941520 RECRUITING
Breast Atypical Hyperplasia; Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ
National Cancer Institute (NCI)
 2024-10-10 PHASE2
NCT07065656 NOT_YET_RECRUITING
Respiratory Failure; Hypoxia; Hypercapnia
National University Hospital, Singapore
 2025-11-01
NCT05973773 ACTIVE_NOT_RECRUITING
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc.
 2023-12-18 PHASE3

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.